Singapore markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.26-0.21 (-0.53%)
At close: 4:00PM EDT

39.26 0.00 (0.00%)
After hours: 4:57PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 598.15B
Enterprise value 397.33B
Trailing P/E 39.58
Forward P/E 112.91
PEG Ratio (5 yr expected) 13.64
Price/sales (ttm)N/A
Price/book (mrq)16.32
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 3-5.19%
S&P500 52-week change 312.20%
52-week high 348.25
52-week low 331.43
50-day moving average 340.16
200-day moving average 340.28

Share statistics

Avg vol (3-month) 32.76M
Avg vol (10-day) 32.38M
Shares outstanding 52.51B
Float 2.46B
% held by insiders 10.01%
% held by institutions 112.17%
Shares short (30 Aug 2020) 49.98M
Short ratio (30 Aug 2020) 43.82
Short % of float (30 Aug 2020) 4N/A
Short % of shares outstanding (30 Aug 2020) 40.40%
Shares short (prior month 30 Jul 2020) 410.36M

Dividends & splits

Forward annual dividend rate 41.89
Forward annual dividend yield 44.79%
Trailing annual dividend rate 31.06
Trailing annual dividend yield 32.68%
5-year average dividend yield 45.23
Payout ratio 459.98%
Dividend date 307 Oct 2020
Ex-dividend date 413 May 2020
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin 19.08%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)7.38%
Return on equity (ttm)63.64%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-2.40%
Gross profit (ttm)22.97B
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly earnings growth (yoy)134.80%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)157.37
Current ratio (mrq)0.96
Book value per share (mrq)2.41

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A